Osteoprotegerin: a link between osteoporosis and arterial calcification?
- 1 July 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 358 (9278) , 257-259
- https://doi.org/10.1016/s0140-6736(01)05494-0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effects of Immunosuppressants on Receptor Activator of NF-κB Ligand and Osteoprotegerin Production by Human Osteoblastic and Coronary Artery Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2001
- Bone Resorption by OsteoclastsScience, 2000
- Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During MenopauseArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infectionJournal of Clinical Investigation, 2000
- Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandNature, 1999
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisNature, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997